電生理設備市場規模、佔有率和成長分析：按類型、按適應症、按最終用途、按地區 - 產業預測，2024-2031 年

2022年全球電生理設備市場規模為60.9億美元，將從2023年的67.8億美元成長到2031年的158億美元，預計預測期內（2024-2031年）複合年成長率為11.16%。 1000萬美元。

擴大採用電生理學 (EP) 測試來預防和治療心房顫動 (AF) 等心臟病，這正在顯著推動市場成長。由於持續監測的需要以及這些設備在非醫院環境中的使用不斷增加，對心律管理設備的需求正在迅速增加。久坐的生活方式、吸菸、過量飲酒和其他風險等因素正在增加心臟衰竭、心臟麻痹和心房顫動的發病率，尤其是在千禧世代。美國疾病管制與預防中心預測，到 2031 年，大約 1,210 萬美國將受到心房顫動的影響。心房顫動在歐洲比其他地方更常見，歐洲心臟學會指出，心律不整導致的心臟麻痹是西方國家死亡的主要原因。每年大約有千分之一的人受到這種疾病的影響。由於心臟病患病率不斷增加，電生理學設備對於心律不整的檢測和治療至關重要，因此擴大被使用。行動心臟監測和動態心電圖 (ECG) 追蹤的進步使得植入式心臟裝置的遠端監測和資料儲存變得更加容易。這一趨勢預計將進一步推動市場成長。此外，向冷凍消融、雷射治療和超音波消融等微創手術的轉變正在推動該領域的發展。例如，2022 年 2 月，美敦力公司的 Freezor 和 Freezor Xtra 心臟冷凍消融焦點導管獲得 FDA核准，該導管旨在治療兒科患者的房室結折返性心動過速 (AVNRT)。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 市場成功因素
• 價值鏈分析
• 主要投資機會
• 市場魅力指數
• 生態系繪圖
• 波特五力分析
• 專利分析
• 價格分析
• 技術分析
• 原料分析
• 供應鏈分析

電生理學設備市場：按類型

• 市場概況
• 消融導管
  • 射頻 (RF) 消融術
  • 冷凍療法、脈衝電場消融
• 診斷導管
• 實驗設備
• 存取裝置

電生理學設備市場：依適應症分類

• 市場概況
• 心房顫動
• 非心房顫動

電生理學設備市場：依最終用途分類

• 市場概況
• 醫院設施
• 門診設施
• 其他

按地區分類的電生理設備市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic（Ireland）
• Boston Scientific Corporation（US）
• Abbott（US）
• GE HealthCare（US）
• Biotronik SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• Koninklijke Philips NV（Netherlands）
• Siemens Healthineers（Germany）
• CardioFocus Inc.（US）
• LivaNova PLC（UK）
• Penumbra, Inc.（US）
• Stereotaxis, Inc.（US）
• Advanced Cardiac Therapeutics, Inc.（US）
• CathRx Ltd.（Australia）
• Osypka Medical GmbH（Germany）
• AngioDynamics, Inc.（US）
• H2O.ai Inc.（US）
• DataRobot, Inc.（US）
• Clarifai, Inc.（US）
• Darktrace plc（UK）
• C3.ai, Inc.（US）

Global Electrophysiology Devices Market size was valued at USD 6.09 billion in 2022 and is poised to grow from USD 6.78 billion in 2023 to USD 15.81 billion by 2031, at a CAGR 11.16 % during the forecast period (2024-2031).

The rising adoption of electrophysiology (EP) tests for both preventing and treating heart conditions like atrial fibrillation (AF) is significantly driving market growth. The demand for cardiac rhythm management equipment has surged due to the need for continuous monitoring and the increasing use of these devices in non-hospital environments. Factors such as sedentary lifestyles, smoking, excessive alcohol consumption, and other risks are contributing to higher incidences of heart failure, sudden cardiac arrest, and AF, particularly among millennials. The Centers for Disease Control and Prevention projects that approximately 12.1 million Americans will be affected by AF by 2031. In Europe, atrial fibrillation is more common than in other regions, with the European Society of Cardiology noting that sudden cardiac arrest due to irregular heart rhythms is a leading cause of death in Western countries. Annually, around one in every 1,000 people is impacted by this condition. Electrophysiology devices, essential for detecting and managing heart arrhythmias, are seeing increased usage due to the growing prevalence of heart disease. The advancements in mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking are making remote monitoring of implanted cardiac devices and data storage more accessible. This trend is expected to further propel market growth. Moreover, the shift towards minimally invasive procedures, such as cryoablation, laser therapy, and ultrasonic ablation, is enhancing the sector's development. For instance, in February 2022, Medtronic received FDA approval for the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters, designed for managing Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophysiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophysiology Devices Market Segmental Analysis

The global electrophysiology device market is segmented based on Product, indication, end-use, and region. Based on type, the market is segmented into Ablation Catheters [Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation], Diagnostic Catheter, Laboratory Devices, Access Devices. Based on indication, the market is segmented into Atrial fibrillation, and Non-Atrial Fibrillation. Based on end-use the market is segmented into Inpatient Facilities, Outpatient Facilities, and Others. Based on region the global Electrophysiology Devices Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is significantly driving the demand for electrophysiology devices. Accurate diagnosis and effective treatment of these conditions are crucial, and electrophysiological devices play a vital role in addressing these needs. As the prevalence of these arrhythmias rises, the reliance on advanced electrophysiology devices for precise diagnosis and management grows. These devices are essential for both detecting and treating complex cardiac irregularities, further boosting their market demand.

Restraints in the Global Electrophysiology Devices Market

The high cost of electrophysiology devices can be a significant barrier to their widespread adoption, especially in areas with constrained healthcare budgets or stringent reimbursement policies. This financial constraint often limits access to these advanced technologies in less affluent regions or healthcare systems with restrictive funding. Due to their expense, the market for electrophysiology devices faces challenges related to affordability and accessibility. The substantial investment required for these devices can restrict their use, particularly in settings where budget limitations or stringent reimbursement policies are prevalent.

Market Trends of the Global Electrophysiology Devices Market

The field of electrophysiology is increasingly leaning towards minimally invasive procedures. Technological advancements and innovations in device design have led to the development of catheter-based techniques that offer precise diagnosis and treatment of cardiac arrhythmias, all while minimizing patient discomfort. These advanced techniques contribute to shorter recovery periods and a reduced risk of complications. By focusing on minimally invasive approaches, the field aims to enhance patient outcomes and streamline the overall treatment process.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Value Chain Analysis
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Porter's Five Forces Analysis
• Patent Analysis
• Pricing Analysis
• Technology Analysis
• Raw Material Analysis
• Supply Chain Analysis

Global Electrophysiology Devices Market by Type

• Market Overview
• Ablation Catheters
  • Radiofrequency (RF)Ablation
  • Cryoablation, Pulse Field Ablation
• Diagnostic Catheter
• Laboratory Devices
• Access Devices

Global Electrophysiology Devices Market by Indication

• Market Overview
• Atrial fibrillation
• Non-Atrial Fibrillation

Global Electrophysiology Devices Market by End User

• Market Overview
• Inpatient Facilities
• Outpatient Facilities
• Others

Global Electrophysiology Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioFocus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stereotaxis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Cardiac Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathRx Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka Medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H2O.ai Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DataRobot, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarifai, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Darktrace plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C3.ai, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments